Another inhibitor worth mentioning is NAHA, a hydroxamic acid derivative that is reported to inhibit cell proliferation and colony formation in breast cancer cells and to reduce tumour weight in vivo by downregulating Cdc20 expression [14]. Here, CDC20 is linked to breast carcinoma.